President’s letter
2020 Metrics
Cycle of Translation
Visionary Gifts
Discovery to Clinic
Innovative Education
Translational Luminaries
Introduction
The Ann Kimbell and John W. Johnson Center for Cellular Therapeutics
The Fondren Food & Health Alliance and The Fondren Inflammation Center
Cockrell Center for Advanced Therapeutics
Paula and Joseph C. “Rusty” Walter III Translational Research Initiative
Jerold B. Katz Academy of Translational Research
result
Outcomes Research
Precision Medicine
CPRIT Funding to Drive New Discoveries in Cancer Therapeutics
Siemens Healthineers and Houston Methodist Imaging Innovation Hub Empowers Researchers to Push the Boundaries
Novel Monoclonal Antibody Treatment Halts Tumor Growth in Deadly Ovarian and Pancreatic Cancers
Houston Methodist Institute for Technology, Innovation & Education (MITIESM)
Can Devices Provide A New Treatment Option for Glioblastoma?
Houston Methodist Hospital’s new Paula and Joseph C. “Rusty” Walter III Tower offers the Most advanced treatments and innovations available
Neuroimaging Offers New Insights into Neurodegeneration
COVID-19 Studies
Restorative Medicine
Houston Methodist and Rice University Launch Center for Translational Neural Prosthetics and Interfaces
Non-invasive Spinal Stimulation Enables Paralyzed People to Stand Unassisted
Dissolvable Implants Enhance the Body’s Ability to Heal Broken Bones
Cell Encapsulation May Hold the Key to Preventing Cell Transplant Rejection
Revolutionizing the Future of Complex Valve Disease Management
Science in Service
of
Medicineresult
President's letter
2020 Metrics
Cycle of Translation
Visionary Gifts of Hope
Introduction
The Ann Kimbell and John W. Johnson Center for Cellular Therapeutics
The Fondren Food & Health Alliance and The Fondren Inflammation Center
Cockrell Center for Advanced Therapeutics
Paula and Joseph C. “Rusty” Walter III Translational Research Initiative
Jerold B. Katz Academy of Translational Research
From Discovery to Clinic
Introduction
Restorative Medicine
Houston Methodist and Rice University Launch Center for Translational Neural Prosthetics and Interfaces
Non-invasive Spinal Stimulation Enables Paralyzed People to Stand Unassisted
Dissolvable Implants Enhance the Body’s Ability to Heal Broken Bones
Cell Encapsulation May Hold the Key to Preventing Cell Transplant Rejection
Revolutionizing the Future of Complex Valve Disease Management
Precision Medicine
CPRIT Funding to Drive New Discoveries in Cancer Therapeutics
An Innovative New Tool to Enable Drug Discovery and Personalized Medicine
Devising a Novel Combination Treatment for Aggressive Double-hit Lymphoma
Expanding the RNAcore to Encompass the Entire Cycle of a Cure
Siemens Healthineers and Houston Methodist Imaging Innovation Hub Empowers Researchers to Push the Boundaries
Novel Monoclonal Antibody Treatment Halts Tumor Growth in Deadly Ovarian and Pancreatic Cancers
Houston Methodist Institute for Technology, Innovation & Education (MITIESM)
Surgical Technology Developed in MITIE Gains FDA Approval
Pushing the Frontier of the Robotics Revolution
Can Devices Provide A New Treatment Option for Glioblastoma?
Houston Methodist Hospital’s new Paula and Joseph C. “Rusty” Walter III Tower offers the Most advanced treatments and innovations available
Neuroimaging Offers New Insights into Neurodegeneration
Translational Luminaries
Discovery to Clinic
Houston Methodist brings new scientific discoveries to patients as rapidly as possible through the full cycle of translation. Our focus is on achieving market adoption and compliance with safety, laws and regulations to give patients quicker access to safe and effective therapies. Our interdisciplinary research teams identify promising discoveries early and accelerate them through the development process, positioning them to make the leap from idea to clinic. Research in Outcomes Research, Precision Medicine and Restorative Medicine aims to help patients maintain their optimal physical and cognitive health profiles by developing new technologies and health plans to preserve, regenerate and rejuvenate the tissues and movement that are impaired due to injury, disease or the normal aging process.
COVID-19 Studies
COVID-19 Spotlights Social Determinants of Health
A novel method of gathering insight into COVID-19 data trends
Researchers meet the challenge of a pandemic
Throughout the pandemic, Houston Methodist was well positioned to meet the urgent need for diagnostics, treatments, vaccines and critical medical technologies
Shedding Light on an Unseen Crisis
New tools build health care worker resiliency
Outcomes Research
Mobile App for Breast Cancer Survivors Promote Healthy Lifestyle Choices and Weight Loss
MOCHA is an interactive resource that helps post-treatment cancer survivors to make healthy lifestyle choices
Mobile App Improves Joint Replacement Surgery Outcomes
MHealth technology can significantly improve both clinical and patient-centered care outcomes
Restorative Medicine
Houston Methodist and Rice University Launch Center for Translational Neural Prosthetics and Interfaces
Houston Methodist collaborates with Rice University on new center
Non-invasive Spinal Stimulation Enables Paralyzed People to Stand Unassisted
The power to stand again
Dissolvable Implants Enhance the Body’s Ability to Heal Broken Bones
A new way to heal
Cell Encapsulation May Hold the Key to Preventing Cell Transplant Rejection
Cell transplantation is a promising option
Revolutionizing the Future of Complex Valve Disease Management
A revolution in heart valves
Precision Medicine
CPRIT Funding to Drive New Discoveries in Cancer Therapeutics
Funds give researchers the opportunity to develop new treatment options
Expanding the RNAcore to Encompass the Entire Cycle of a Cure
MITIE surgical technology approved by FDA
Imaging Innovation Hub Empowers Researchers to Push the Boundaries
The Research Institute is home to one of the world’s most powerful MRI machines
An innovative technology that provides anti-cancer therapy through a wearable device
A research collaboration has identified a promising new antibody therapy for late-stage ovarian and pancreatic cancers
Houston Methodist Institute for Technology, Innovation & Education (MITIESM)
MITIE surgical technology approved by FDA
Can Devices Provide A New Treatment Option for Glioblastoma?
An innovative technology could provide anti-cancer therapy through a wearable device.
Paula and Joseph C. “Rusty” Walter III Tower offers advanced and innovative treatments
A center for advanced treatments and innovation
Neuroimaging Offers New Insights into Neurodegeneration
New discovery reveals a window of opportunity for treatment for Alzheimer’s Disease patients